Collecting prostate cancer care details and prostate tissue samples
Part of Cancer, Kidney & urinary clinical trials.
This trial enrolls adults who are being evaluated or treated for possible or confirmed prostate cancer and allows researchers to collect prostate tissue. It may help improve understanding of prostate cancer over the course of diagnosis and standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are being checked for prostate cancer or treated for it
- You can have usual prostate tests or procedures as part of your care (diagnosis, treatment, or follow-up)
- Your general fitness level is good to fair (ECOG 0–2)
- You can and will sign informed consent
- You meet at least one prostate cancer clue: higher PSA, abnormal prostate exam, abnormal prostate MRI, or certain family cancer history
- Your other health problems must not be severe enough to prevent testing or treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood samples from adults with prostate cancer. It may help researchers learn more about the disease or how treatments work, without directly testing a new drug in the eligibility you provided.
This study collects prostate tissue samples from men who are either at higher risk due to a gene change or are getting a biopsy or prostate surgery for routine care. The samples are stored in a biobank for future research on prostate cancer.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
This study asks men with prostate cancer about their experience preparing for and joining clinical trials. It may help improve how future trials are explained and supported for patients.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.